AbbVie generated $62.8B in trailing twelve-month revenue, up 0.1% year-over-year. Net income was $3.6B with a 5.79% net margin. Gross margin stands at 70.68% and operating margin at 24.41%. Diluted EPS is $2.03, which declined 0.1% year-over-year. Based on the Q1 2026 filing.